Herantis Pharma Plc’s to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
Herantis Pharma Plc Company release 11 Jan 2021 at 09:00 am EET Herantis Pharma Plc (“Herantis”), an innovative drug development company pioneering new disease modifying and regenerative biologic and gene therapies, announced today that Craig Cook, Chief Executive Officer of Herantis, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference taking place January 11-14, 2021. The video webcast presentation will be available for viewing on-demand beginning Monday, January 11, 2021, at 6:00 ET / 13:00 EET / 12:00 CET. To access the live webcast of Herantis’ live